跳至主要内容
临床试验/RBR-2zhgjw
RBR-2zhgjw进行中(未招募)3 期

se of sodium nitroprusside in repeated doses, in potentiation of typical and atypical antipsychotics, and its effect on negative symptoms in treatment-resistant schizophrenia

niversidade Federal de São Paulo0 个研究点开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 60Y(—)

入选标准

  • Male or female gender; diagnosis of schizophrenia and antipsychotic treatment; be of legal age and be between the ages of 18 and 60; refractory population, ie patients who have used at least two typical or atypical antipsychotics, for at least 6 weeks each of the antipsychotics.

排除标准

  • Relevant medical condition (cardiovascular diseases, neurological diseases, renal failure, liver disease, hypothyroidism, hyponatremia, hypovitaminosis B12, pregnancy, breastfeeding); history of hypersensitivity and / or allergy to sodium nitroprusside; diagnosis of substance abuse or dependence according to DSM-IV-TR criteria.

研究者

发起方
niversidade Federal de São Paulo

相似试验